Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Liabilities and Shareholders Equity (2016 - 2018)

Armata Pharmaceuticals (ARMP) has disclosed Liabilities and Shareholders Equity for 6 consecutive years, with $10.6 million as the latest value for Q3 2018.

  • Quarterly Liabilities and Shareholders Equity fell 22.94% to $10.6 million in Q3 2018 from the year-ago period, while the trailing twelve-month figure was $36.7 million through Dec 2018, down 32.38% year-over-year, with the annual reading at $11.1 million for FY2017, 38.64% down from the prior year.
  • Liabilities and Shareholders Equity hit $10.6 million in Q3 2018 for Armata Pharmaceuticals, down from $11.7 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $38.6 million in Q1 2015 to a low of $10.6 million in Q3 2018.
  • Historically, Liabilities and Shareholders Equity has averaged $24.5 million across 5 years, with a median of $28.3 million in 2016.
  • Biggest five-year swings in Liabilities and Shareholders Equity: grew 10.05% in 2015 and later tumbled 49.39% in 2017.
  • Year by year, Liabilities and Shareholders Equity stood at $28.6 million in 2014, then increased by 10.05% to $31.5 million in 2015, then plummeted by 42.36% to $18.2 million in 2016, then crashed by 38.64% to $11.1 million in 2017, then fell by 4.66% to $10.6 million in 2018.
  • Business Quant data shows Liabilities and Shareholders Equity for ARMP at $10.6 million in Q3 2018, $11.7 million in Q2 2018, and $14.4 million in Q1 2018.